Patient Education and Counseling
Volume 58, Issue 1 , Pages 13-26 , July 2005

Reduction in uptake of PSA tests following decision aids: systematic review of current aids and their evaluations

  • Rhodri Evans

      Affiliations

    • Department of Primary Care, University of Wales Swansea Clinical School, Singleton Park, Swansea SA2 8PP, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 1792 513489; fax: +44 1792 513430.
    • ,
  • Adrian Edwards

      Affiliations

    • Department of Primary Care, University of Wales Swansea Clinical School, Singleton Park, Swansea SA2 8PP, UK
    • ,
  • Joanne Brett

      Affiliations

    • Cancer Research UK Primary Care Education Research Group, Oxford, UK
    • ,
  • Mike Bradburn

      Affiliations

    • Cancer Research UK Medical Statistics Group, Oxford, UK
    • ,
  • Eila Watson

      Affiliations

    • Cancer Research UK Primary Care Education Research Group, Oxford, UK
    • ,
  • Joan Austoker

      Affiliations

    • Cancer Research UK Primary Care Education Research Group, Oxford, UK
    • ,
  • Glyn Elwyn

      Affiliations

    • Department of Primary Care, University of Wales Swansea Clinical School, Singleton Park, Swansea SA2 8PP, UK

Received 10 November 2003 ,Revised 4 May 2004 ,Accepted 5 June 2004.

References 

  1. Welch H, Schwartz LM, Woloshin S. Are increasing 5-year survival rates evidence of success against cancer?. JAMA. 2000;283:2975–2978
  2. Chodak GW. Comparing treatments for localized prostate cancer — persisting uncertainty. JAMA. 1998;280:1008–1010
  3. Burack RC, Wood DP. Screening for prostate cancer — the challenge of promoting informed decision making in the absence of definitive evidence of effectiveness. Med. Clin. North Am. 1999;83:1423
  4. National Screening Committee . Prostate cancer risk management programme. UK: National Screening Committee; 2001;
  5. O’Connor AM, Stacey D, Entwistle V, Llewellyn-Thomas H, Rovner D, Holmes-Rovner M, et al. Decision aids for people facing health treatment or screening decisions (Cochrane review). The Cochrane Library; 2003;
  6. O’Connor AM, Rostom A, Fiset V, Tetroe J, Entwistle V, Llewellyn-Thomas H, et al. Decision aids for patients facing health treatment or screening decisions: systematic review. BMJ. 1999;319:731–734
  7. Edwards A, Hood K, Matthews EJ, Russell D, Russell IT, Barker J, et al. The effectiveness of one-to-one risk communication interventions in health care: a systematic review. Med. Decis. Making. 2000;20:290–297
  8. Jepson R, Clegg A, Forbes C, Lewis R, Sowden A, Kleijnen J. The determinants of screening uptake and interventions for increasing uptake: a systematic review. Health Technol. Assess. 2000;4:14
  9. Matthews EJ, Edwards A, Barker J, Bloor M, Covey J, Hood K, et al. Efficient literature searching in diffuse topics: lessons from a systematic review of research on communicating risk to patients in primary care. Health Libr. Rev. 1999;16:112–120
  10. O’Connor AM, Stacey D, Rovner D, Holmes-Rovner M, Tetroe J, Llewellyn-Thomas H, et al. Decision aids for people facing health treatment or screening decisions. The Cochrane Library; 2001;
  11. Edwards A, Unigwe S, Elwyn G, Hood K. Personalised risk communication in health screening programs. Cochrane Database of Systematic Reviews; 2003 [review].
  12. Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining several results in meta-analysis. In:  Altman D editors. Systematic reviews in health care: meta-analysis in context. London: BMJ Books; 2001;p. 285–312
  13. Cancer Information Services . Questions and answers about the prostate-specific antigen (PSA) test. USA: National Cancer Institute; 2001;
  14. VA Medical Centre Minneapolis . Early prostate cancer information leaflet. Minneapolis: VA Medical Centre; 2001;
  15. American Institute for Cancer Research . Reducing your risk of prostate cancer. Washington: American Institute for Cancer Research; 1999;
  16. Foundation for Informed Medical Decision-Making . The PSA decision: what you should know. Hanover, NH, USA: Foundation for Informed Medical Decision-Making; 1994;
  17. Wolf AMD, Nasser JF, Wolf AM, Schorling JB. The impact of informed consent on patient interest in prostate-specific antigen screening. Arch. Intern. Med. 1996;156:1333–1336
  18. NHS Centre for Reviews and Dissemination . Screening for prostate cancer — information for men considering or asking for PSA tests (Effectiveness matters). NHS Centre for Reviews and Dissemination; 1997;
  19. Brett J, Watson E, Bukach C, Austoker J. PSA testing for prostate cancer: an information sheet for men considering a PSA test. Oxford: Cancer Research UK Primary Care Education Research Group, University of Oxford; 2002;
  20. Volk RJ, Cass AR, Spann SJ. A randomized controlled trial of shared decision making for prostate cancer screening. Arch. Fam. Med. 1999;8:333–340
  21. Volk RJ, Spann SJ, Cass AR, Hawley ST. Patient education for informed decision making about prostate cancer screening: a randomized controlled trial with one-year follow-up. Ann. Fam. Med. 2003;1:22–28
  22. Frosch DL, Kaplan RM, Felitti V. Evaluation of two methods to facilitate shared decision making for men considering the prostate-specific antigen test. J. Gen. Intern. Med. 2001;16:391–398
  23. Flood AB, Wennberg JE, Nease RF, Fowler FJ, Ding J, Hynes LM. The importance of patient preference in the decision to screen for prostate cancer. J. Gen. Intern. Med. 1996;11:342–349
  24. Wilt TJ, Paul J, Murdoch M, Nelson D, Nugent S, Rubins HB. Educating men about prostate cancer screening (A randomized trial of a mailed pamphlet). Eff. Clin. Pract. 2001;4:112–120
  25. Schapira MM, VanRuiswyk J. The effect of an illustrated pamphlet decision-aid on the use of prostate cancer screening tests. J. Fam. Pract. 2000;49:425–427
  26. Hammond CS, Wasson JH, Walker-Corkery E, Fowler FJ, Barry MJ. A frequently used patient and physician-directed educational intervention does nothing to improve primary care of prostate conditions. Urology. 2001;58:875–881
  27. Beggs V, Wennberg JE, Llewellyn-Thomas H. Shared decision aids: do they affect preference formation? Shared Decision Making Summer School. Oxford, UK; 2001.
  28. Wilkins E, Lowery J, Hamill J. The impact of shared decision making in PSA screening. Med. Decis. Making. 1999;19:525;[abstract]
  29. Davison BJ, Kirk P, Degner LF, Hassard TH. Information and patient participation in screening for prostate cancer. Patient Educ. Couns. 1999;37:255–263
  30. Edwards A, Hailey S, Maxwell M. Psychological interventions for women with metastatic breast cancer. Cochrane Database of Systematic Reviews; 2004 [review].
  31. Edwards A, Russell IT, Stott NCH. Signal and noise in the evidence base for medicine — going beyond hierarchies of evidence?. Fam. Pract. 1998;15:319–322
  32. Sacks H, Chalmers TC, Smith H. Randomised versus historical controls for clinical trials. Am. J. Med. 1982;72:233–238
  33. Colditz GA, Miller JN, Mosteller F. How study design affects outcomes in comparisons of therapy. Stat. Med. 1989;8:441–454
  34. Rollnick S, Mason P, Butler C. Health behaviour change: a guide for health care professionals. Churchill Livingstone, London; 1999.
  35. Edwards A, Elwyn G, Hood K, Rollnick S. Judging the “weight of evidence” in systematic reviews: introducing rigour into the qualitative overview stage by assessing signal and noise. J. Eval. Clin. Pract. 2000;6:177–184
  36. Schwartz D, Lellouch J. Explanatory and pragmatic attitudes in therapeutic trials. J. Chronic Dis. 1967;20:637–648

PII: S0738-3991(04)00199-5

doi: 10.1016/j.pec.2004.06.009

Patient Education and Counseling
Volume 58, Issue 1 , Pages 13-26 , July 2005

Article Tools

* Image Usage & Resolution